




SpaceX received FAA clearance for Starship to fly again, with Starship Flight 13 potentially as early as Thursday, July 16 at 6:45 p.m. ET, and an accelerated cadence cited by Raymond James. However, shares reportedly sold off on the news, and China’s successful reusable Long March 10B test narrows the technology gap versus SpaceX—an offsetting valuation risk. Net: near-term operational optimism is tempered by competitive concerns and weaker investor follow-through.
The market mechanism here is valuation, not near-term cash flow. For SPCX, the real asset is the scarcity premium attached to a perceived launch monopoly; a credible Chinese reusable-launch proof point does not change 1Q revenue, but it can compress the terminal multiple by forcing investors to discount future pricing power and cadence advantages. The key distinction is between a one-off technical milestone and a repeatable manufacturing/turnaround system — the latter is what justifies premium infrastructure-like valuation.
Second-order effects are more interesting than the headline move. If China can iterate toward lower launch costs, domestic and allied governments may become more willing to dual-source launch capacity, which would favor defense-adjacent launch integrators and sovereign-space supply chains over pure-play frontier narratives. That is a months-to-years story; over days, the bigger driver is whether Thursday’s test reinforces or undermines the “operational cadence” premium embedded in SPCX.
Contrarian view: the consensus is likely overreacting to the Chinese test as if first landing equals parity. The bottleneck is not reaching the ocean platform once; it is maintaining high-flight-rate reliability, refurbishment economics, and payload economics across multiple cycles. If the next 1-3 months produce another clean SpaceX flight sequence while China stalls on repeatability, this will look like a sentiment dip rather than a fundamental moat break. The thesis is falsified if China demonstrates back-to-back reusable launches within 60-90 days or if SPCX guidance/secondary pricing starts reflecting sustained margin erosion rather than optionality.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mixed
Sentiment Score
-0.05
Ticker Sentiment